Worldwide more than eight million people die of cancer each year. The chance of survival depending on the type of cancer, the stage at which it is diagnosed and the speed with which appropriate treatment is launched. Skyline Diagnostics, a Dutch company associated with the Erasmus Medical Center in Rotterdam, has developed a unique diagnostic test for…

The first genome-wide study to demonstrate an inherited genetic basis for racial and ethnic disparities in cancer survival linked Native American ancestry with an increased risk of relapse in young leukemia patients. The work was done by investigators at St. Jude Children's Research Hospital, internationally recognized for its pioneering research and treatment of children with cancer, and the Children's Oncology Group (COG).



Along with identifying Native…

For several decades, researchers have been linking genetic mutations to diseases ranging from cancer to developmental abnormalities. What hasn't been clear, however, is how the body's genome sustains such destructive glitches in the first place. Now a team of scientists and research collaborators at the Mayo Clinic provide an unprecedented glimpse of a little-understood gene, called MMSET, revealing how it enables…

Every year more than 146,000 Americans are diagnosed with colorectal cancer [1], the third most common type of cancer in the United States. It also is the third highest cause of cancer death, killing nearly 50,000 people annually, more than who die each year on the nation’s roadways. This cancer affects men and women in nearly equal numbers.



In patients with stage III colon cancer who have undergone complete resection of the primary tumor or for palliative…

Ninety percent of children who lived in a house where an adult smoked had evidence of tobacco-related carcinogens in their urine, according to research presented at the Ninth AACR Frontiers in Cancer Prevention Research Conference, held in Philadelphia from November 7-10, 2010.



The average amount of tobacco metabolites in children aged one month to 10 years old was 8 percent of what is found in a smoker, said the lead researcher Janet L. Thomas, Ph.D.,…

The North Central Cancer Treatment Group (NCCTG), a national clinical research group sponsored by the National Cancer Institute, plans to conduct a Phase II study of brostallicin in combination with cisplatin in patients with metastatic triple-negative breast (mTNBC) cancer. These cancers…

The European Medicines Agency (EMEA) Pediatric Committee (PDCO) today released its findings requested that Cell Therapeutics, Inc submit an updated Pediatric Investigation Plan (PIP) for pixantrone following discussions about the preclinical and clinical pixantrone data, including PIX301, and the desire to explore the potential benefits pixantrone may offer to children with hematologic cancer.

Following the request Cell Therapeutics, cexpects to…